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The recent resurgence and current epidemics
of tuberculosis (TB) in many developed
countries have focused attention on trans-
mission in high-risk settings (1–3). The
prevalence of human immunodeficiency
virus infection, the high case fatality rate of
multidrug-resistant TB especially among
AIDS patients, and transmission from
unsuspected TB patients support the impor-
tance of environmental control measures in
high-risk settings (4–6). Ultraviolet germici-
dal irradiation (UVGI) that occurs in the
upper portion of air in a room has been con-
sidered an environmental control measure
that could economically reduce exposure to
Mycobacterium tuberculosis (MTB) droplet
nuclei (7,8). For this approach, air above
people’s heads (usually higher than 2.1 m) is
subject to 254 nm germicidal ultraviolet C
(UVC), whereas lower-room air, where peo-
ple actually stay and breathe, is not irradi-
ated. A large volume of air can be disinfected
without overexposing people to UVC.
Currently, upper-room UVGI is recom-
mended by the Centers for Disease Control
and Prevention as a supplemental approach
for preventing transmission of TB (9).
Three factors are important in the effi-
cacy of upper-room UVGI: the upper-room
disinfection rate, air volume ratio for the
irradiated upper room and the nonirradiated
lower room, and the air mixing rate between
the upper and lower room (10). The disin-
fection rate in the upper room depends on
UV dose and UV susceptibility of the
microorganism. UV dose is the product of
UV irradiance and exposure time (11).
Susceptibility of microorganisms to UV
depends on the complexity of the microor-
ganism’s structure, its repairability, and its
general sensitivity (12). As the UV dose
becomes higher and microbial susceptibility
to UVGI increases, the efficacy of upper-
room UVGI increases. The desirable sce-
nario is to maintain the maximum amount
of UV irradiance in the upper part of the
room while minimizing people’s exposure to
UVC in the lower part of the room. The
American Conference of Governmental
Industrial Hygienists currently recommends
that measured UV irradiance in the lower
room should be ≤ 6 mJ/cm2 (0.2 µW/cm2)
for 8 hr exposure (13). The current criterion
for installing upper-room UVGI is one 30-
W (input) lamp or two 15-W lamps for each
200 square feet (19 m2) of floor area
(14–16). A 30-W lamp for every seven occu-
pants has been recommended for crowded
conditions. 
The mixing rate between air in the upper
and the lower part of the room is also impor-
tant in the efficacy of upper-room UVGI
(17). This air mixing occurs mainly by con-
vection caused by a vertical temperature gra-
dient in nonmechanically ventilated rooms.
When a room has a mechanical ventilation
system, ventilation type and locations of
supply and exhaust also play important roles
in vertical air mixing. The presence of a mix-
ing fan (or ceiling fan) also affects vertical air
mixing. The volume of upper-room irradi-
ated air and lower room nonirradiated air
depends on the room dimensions (especially
ceiling height), the type and number of UV
fixtures, and reflection characteristics of
room surfaces (18,19).
Several different types (ceiling-mounted,
wall-mounted, and corner-mounted) of UV
ﬁxtures are commercially available for upper-
room air irradiation (10,19). Typical ceiling-
mounted fixtures are vertical tubes with
disk-shaped louvers that conﬁne emission to
a horizontal direction and irradiate through-
out all 360 degrees. Another type of ceiling-
mounted fixture is the open-tube fixture
with upward-facing ﬂanges that block down-
ward radiation. Because this type of UV ﬁx-
ture radiates upward through 180 degrees,
reﬂection from the ceiling should be consid-
ered. Wall-mounted fixtures have parallel
louvers that are usually coated with a nonre-
ﬂective material (19). These parallel louvers
can block downward radiation and confine
emission to a horizontal direction. Louvered
wall fixtures are equipped with a rear-
mounted, polished aluminum parabolic
reflector to focus lamp emissions and to
maximize irradiation. 
Although several studies have reported the
efﬁcacy of upper-room UVGI in inactivating
airborne microorganisms (17,20–23), data
with Mycobacterium are very limited (14,24).
Only one study has characterized the cur-
rently available louvered UV fixtures using
Mycobacterium parafortuitum (24). One of
limitations in that study is that the suscepti-
bility of M. parafortuitum to UV has not been
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Articles
In this study, we explored the efﬁcacy of upper-room ultraviolet germicidal irradiation (UVGI) in
reducing the concentration of Serratia marcescens and Mycobacterium bovis bacille Calmette-
Guérin (BCG) aerosols in an enclosed space. We constructed a facility (4.5 m × 3 m × 2.9 m) in
which both ceiling- and wall-mounted UV ﬁxtures (UV output: 10W and 5W respectively) were
installed. The use of ceiling- and wall-mounted UV ﬁxtures (total UV output: 15W) without mix-
ing fan reduced the concentration of S. marcescens aerosols by 46% (range: 22–80%) at 2 air
changes per hour (ACH) and 53% (range: 40–68%) at 6 ACH. The use of ceiling- and wall-
mounted UV ﬁxtures with mixing fan increased the UV effectiveness in inactivating S. marcescens
aerosols to 62% (range: 50–78%) at 2 ACH and to 86% (81–89%) at 6 ACH. For BCG aerosols,
UV effectiveness in inactivating BCG aerosols at 6 ACH were 52% (range: 11–69%) by ceiling-
mounted UV ﬁxture only (total UV output: 10W) and 64% (51–83%) by both ceiling- and wall-
mounted UV fixtures (total UV output: 15W). Our results indicated that the equivalent
ventilation rate attributable to upper-room UVGI for BCG aerosols ranged from 1 ACH to 22
ACH for ceiling-mounted UV fixtures and from 6.4 ACH to 28.5 ACH for ceiling- and wall-
mounted UV ﬁxtures. Both generalized linear and generalized additive models were ﬁtted to all
our data. The regression results indicated that the number of UV ﬁxtures, use of mixing fan, and
air exchange rate significantly affected UV effectiveness (p < 0.01, 0.01, 0.01 respectively).
However, the strain difference (S. marcescens vs. BCG) appeared less important in UV effective-
ness (p = 0.26). Our results also indicated that UV effectiveness increased at higher temperature
(p < 0.01), lower dry-bulb temperature (p = 0.21), and colder air from a supply grill located near
the ceiling (p = 0.22). Key words: aerosols, BCG, Mycobacterium tuberculosis, Serratia marcescens,
TB, UV. Environ Health Perspect 110:95–101 (2002). [Online 19 December 2001]
http://ehpnet1.niehs.nih.gov/docs/2002/110p95-101ko/abstract.htmlcompared to that of virulent MTB, so extrap-
olation to efficiency in controlling MTB
aerosols is problematic. In fact, there is broad
variability among Mycobacterium species with
respect to UV susceptibility. For example, M.
phlei is apparently 6–10 times more resistant
to UV than is MTB (14). Another important
limitation is that Mycobacterium aerosols were
suspended in distilled water (24), a very dif-
ferent condition from that of bacterial
aerosols released from the human respiratory
tract. Suspending medium for aerosols greatly
affects both bacterial survival in air and UV
susceptibility of airborne bacteria (25,26).
Therefore, suspending media for studying
microbial aerosols must simulate the real-
world aerosols as closely as possible. In this
study, we used commercially available UV
units. We characterized the effect of air
exchange rate and air mixing on the efﬁcacy
of upper room UVGI with Serratia marcescens
aerosols in simulated saliva [10% fetal calf
serum (FCS)] with and without upper-room
UVGI. We used M. bovis bacilli Calmette-
Guérin (BCG) as a surrogate for virulent
MTB. BCG has been extensively compared
to MTB and is reported to have the same UV
susceptibility as virulent MTB (14). Finally,
we used 10% FCS as a surrogate for saliva.
Materials and Methods
Bacterial culture methods and preparation
of cell stocks. We obtained S. marcescens and
BCG from American Type Culture Collection
(ATCC 8195 and ATCC 35737, respec-
tively; ATCC, Manassas, VA).We maintained
S. marcescens on nutrient agar slants (DIFCO,
Detroit, MI) at room temperature. A loopful
of cells was inoculated into 100 mL nutrient
broth and cultured at 25°C for 24 hr with
agitation (200 rpm). We placed each milliliter
of cultured cells in a 1.5 mL Eppendorf tube
(Fisher Scientiﬁc, Pittsburgh, PA), washed it
with 1 mL phosphate-buffered saline (PBS)
(pH = 7.4) twice, and harvested it by cen-
trifugation at 1,500 rpm for 10 min.
Harvested cells were stored at –70°C for
later experiments. Several of these cell
aliquots were sampled, serially diluted, and
cultured on nutrient agar to appropriate
dilutions for aerosolization. We suspended
two cell pellets in 150 mL PBS to a cell con-
centration of approximately 106 colony-
forming units (CFU) per milliliter. We
added FCS (DIFCO) to a final concentra-
tion of 10% to simulate the protein concen-
tration of saliva (3.5 mg/mL) (27).
We maintained the BCG strain on
Lowenstein-Jensen agar (Remel, Lenexa, KS)
plates at 37°C. A loopful of cells was inocu-
lated into 500 mL of Middlebrook broth
(DIFCO) containing 0.02% Tween 80, and
cultured at 37°C for 3–4 weeks with gentle
agitation (100 rpm). We harvested cultured
cells by centrifugation at 1,500 rpm for 10
min, suspended them in 50 mL PBS, and
homogenized them using a tissue grinder to
break up large clumps. We filtered
homogenates using 5 µm cellulose nitrate
membrane filters (Whatman, Maidstone,
England) to remove remaining cell clumps.
We harvested filtered cell suspensions and
resuspended them in 30 mL PBS. Each mil-
liliter of 30-mL cell suspension was allocated
into a 1.5 mL Eppendorf tube, washed with
1 mL PBS twice, and harvested by centrifu-
gation at 1,500 rpm for 10 min. We stored
harvested cells at –70°C for later experi-
ments. For aerosolization, we prepared cell
suspensions in the same way as described
above for S. marcescens, and we adjusted cell
concentration to approximately 105
CFU/mL with 10% FCS. The 6-jet Collison
nebulizer (BGI, Waltham, MA) was initially
loaded with about 70 mL of cell suspension,
and the remaining cell suspension was stored
at 4°C during the experiment. We added
suspension to the nebulizer every 45 min to
maintain a constant aerosolization rate.
We loaded either nutrient agar or
Middlebook agar plates into a six-stage
Andersen culture plate impactor (Andersen
Sampler Inc., Atlanta, GA) for the experi-
ments with S. marcescens or BCG respec-
tively. We counted colonies after incubation
for 48 hr at room temperature for S.
marcescens and for 3 weeks at 37°C for BCG. 
Description of the experimental facility.
The facility was built on the roof of a four-
story building in an urban setting in Boston
at an elevation of about 19 m from the
ground (Figure 1). The size of the facility is
15.6 m2 (5.2 m × 3 m) with a ceiling height
of 2.9 m. It contains an experimental cham-
ber (4.5 m × 3 m) and an anteroom (0.7 m
× 3 m) separated by a partition and an inte-
rior door. Interior wall and ceiling surfaces
are finished with vinyl-covered sheetrock,
and the ﬂoor is a composite. The facility has
an exterior door to the anteroom and three
double insulated glazed windows. The inte-
rior door separating the anteroom from the
chamber was sealed with vinyl tape during
the experiments. The chamber is ventilated
through an upper-room supply grill and a
lower-room air exhaust grill, both ﬁtted with
HEPA ﬁlters to prevent microbiologic con-
tamination of the supply air and to prevent
release of microbiologic agents into the
exhaust air. The mechanical ventilation rate
was adjusted by a damper located in the
exhaust duct to approximately 49 ft3/m for 2
air changes per hour (ACH) or 147 ft3/m for
6 ACH. We measured the air exchange rate
in the exhaust duct using a hot wire
anemometer (Model 8360; TSI Inc., St.
Paul, MN) and checked it using the decay
rate of a tracer gas (sulfur hexaﬂuoride).
The chamber is essentially airtight, and
the air exchange rate estimated by mechanical
ventilation was almost identical to the decay
of tracer gas. The room is maintained under
negative pressure compared with the ante-
room and outdoors using a balance of supply
and exhaust air, and was checked by smoke
test. The negative pressure was always moni-
tored during experiments by manometer.
During experiments, temperature and rela-
tive humidity (RH) in the room chamber
were continuously monitored in front of the
exhaust duct by an electrical sensor (Model
Humeter 50Y; VAISALA, Woburn, MA).
We did not measure the temperature or the
ratio of the partial pressure of the water vapor
to the saturation vapor pressure for the same
RH as the supply air during the experiments.
Because untreated outdoor air was intro-
duced directly into the room through the
HEPA ﬁlter, air temperatures inside reﬂected
those outdoors. We estimated the tempera-
ture and RH of supply air with both hourly
local climatologic data from the National
Oceanic and Atmospheric Administration
(28) and Boston center urban data from
Massachusetts Department of Environmental
Protection-Div A (29). These two data sets
were not signiﬁcantly different. A 20-in box
fan (Cyclone model number 3510; Lasko,
Franklin, TN) was located in the center of
the room chamber.
Aerosol generation and sampling devices.
Aerosols were generated by a 6-jet Collison
nebulizer (Model CN-38; BGI). The nebu-
lizer was located outside the test room cham-
ber, and the aerosols were introduced to the
center of the chamber through a perma-
nently installed stainless steel pipe. A multi-
perforated stainless steel hollow sphere was
connected to the end of the steel pipe,
thereby projecting condensation in nuclei-
like particles more or less uniformly
throughout the chamber. A diagram of the
aerosol generation device appears in Figure
2A. Particle deposition in this aerosol supply
line (approximately 1.5 m length) is expected
to be negligible compared to the number of
cells aerosolized (< 1%) (30).
The sampling line through which we
collected all samples penetrated an exterior
wall and was sealed airtight to the structure
at the point of entry and the inner wall sur-
face. A sampling line was permanently
installed at the exhaust grill through sam-
pling ports, and all other parts of the sam-
pling devices were located outside the
chamber. An outer tube was sealed airtight
to the inner and outer facility walls. An
inner tube, approximately 1.5 m long, had
O-ring seals attached at appropriate intervals
to assure that two O-rings were always inside
the outer tube, providing a double seal
between the facility interior and exterior.
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Andersen culture plate impactor (Andersen,
Inc., Atlanta, GA) and other sampling
devices (BGI) as presented in Figure 2B. The
discharge of the sampler was fit with flat
HEPA ﬁlter material to remove microorgan-
isms not recovered by the Andersen sampler.
A high static pressure pump was connected
to the sampling device at the downstream
end and provided the desired sampling rate,
which we monitored by both a venturi meter
and a rotameter. Loss of bacterial aerosols
during transport through the sampling line
is expected to be negligible (30).
UV irradiance and ﬁxtures. We installed
commercially available (wall-mounted and
ceiling-mounted) UVGI fixtures inside the
room. The wall-mounted UV ﬁxture (Model
40-1080A; Atlantic Ultraviolet Corp., Bay
Shore, NY) contains one 23-W UV lamp
(UV output: 5 W). The ceiling-mounted UV
fixture (Model PMCUGI-4PL; Lumalier,
Memphis, TN) contains four 9-W UV lamps
(Total UV output: 10 W). Both types of UV
ﬁxtures have low-pressure mercury discharge
lamps and louvers producing a narrow verti-
cally collimated beam. The ceiling-mounted
UV ﬁxture was suspended from the center of
the chamber with the bottom of the ﬁxture
at a height of 2.3 m from the floor. The
wall-mounted UV fixture was placed on a
shelf located at a height of 2.1 m. Following
the manufacturers’ recommendations, we
operated both UV fixtures for 100 hr to
allow an adequate break-in period before
experiments began.
We measured the distribution of UV
irradiation for the UV ﬁxtures by radiometer
(Model SEL240 3660; International Light,
Inc., Newburyport, MA). We mapped UV
irradiation by measuring at graduated dis-
tances and angles from the horizontal and
vertical centerlines of the ﬁxtures before the
initial experiment. We monitored UV irradi-
ance from the anteroom through a small
hole covered with a fused silica plate located
between the experimental chamber and the
anteroom during the experiments. We
assessed offsets between measurements
through the peep hole and room UV irradi-
ance in the upper room. 
Experimental procedure for measuring
the efficacy of upper-room UVGI. The
mechanical ventilation rate (ACH) was set
up at least one day before the experiments.
S. marcescens or BCG cells were aerosolized
by 6-jet Collison nebulizer, which generated
a 2 µm mass median particle diameter (31).
Air pressure for the nebulizer was main-
tained at 138 kPa (20 lb/in2). Bacterial
aerosols were generated at a rate of 1.5 × 106
CFU/min and introduced into the room
chamber as described above. Air containing
the microorganism aerosols was pulled from
the chamber into the sampling line at a ﬂow
rate of 1 ft3/m and then into the Andersen
culture plate impactor. We determined the
concentration of airborne culturable
microorganisms from the total volume of
sampled air and the number of resulting
colonies. Because most sampled cells
(> 90%) were recovered on the third to ﬁfth
stages of the Andersen sampler, correspond-
ing to a range of 1.1–4.7 µm, and because
particles in this size range present the great-
est risk for airborne infection, we loaded
only the second and fifth stages with agar
plates to measure the efﬁcacy of upper-room
UVGI; the range of particle size recovered
from ﬁfth stage (1.1–4.7 µm) was the focus
of our interest.
We tested the efficacy of upper-room
UV irradiation in inactivating airborne
microorganisms in a steady-state condition.
As a pilot study, we aerosolized S. marcescens
into the room chamber and took a series of
4-min samples (at 10, 20, 30, 40, 50, 60, 75,
and 90 min) after aerosol generation began
(time = 0) to determine the time required to
reach a steady state at 6 ACH. The concen-
trations of airborne S. marcescens rapidly
increased until 20 min after aerosol genera-
tion began and were relatively constant
thereafter. We also determined the time to
reach reduced concentrations after turning
on the upper-room UVGI lamps. The con-
centration of airborne S. marcescens rapidly
decreased until 30 min after the UV expo-
sure began and remained relatively constant
thereafter. Estimation based on box models
indicated that approximately 30 mins (at 6
ACH) or 90 min (at 2 ACH) would be
needed to reach more than 95% of the
steady-state concentration. The results from
S. marcescens experiments reasonably coin-
cided with the box model estimates. 
We also tested the effect of air exchange
rate and mixing fan on the efficacy of 
upper-room UVGI with S. marcescens. We
measured concentrations of airborne
microorganisms with and without upper-
room UVGI at two air exchange rates (2
ACH and 6 ACH) with both ceiling- and
wall-mounted UV fixtures individually or
together. We measured concentrations of
S. marcescens aerosols with and without mix-
ing fans with and without upper-room
UVGI (ceiling- and wall-mounted UV fix-
tures) at 6 ACH. We measured the efﬁcacy
of upper-room UVGI in inactivating BCG
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Figure 1. Diagram of experimental room chamber. a, ceiling-mounted UV ﬁxture; b, wall-mounted UV ﬁx-
ture; c, aerosol generator; d, box fan; e, air supply grill; f, air exhaust grill; g, sampling device; h, windows.
Figure 2. Diagram of aerosol generating and sampling devices. (A) Aerosol generating device; a, pressured
air line; b, pressure gauge and regulator; c, polycarbonate ﬁlter; d, valve; e, collison nebulizer; f, diffuser; g,
pipe line. (B) Sampling device; a, outer tube; b, inner tube; c, O-ring; d, pressured air; e, purge line; f, valve;
g, Andersen sampler; h, ﬂat HEPA ﬁlter; i, venturi meter; j, manometer; k, vacuum pump; l, rotameter.aerosols without the mixing fan at 6 ACH
with both ceiling-mounted and combined
ceiling- and wall-mounted UV ﬁxtures.
One unshaded window and a lighting
system, typical of conditions in patient
rooms, were present constantly throughout
the experiments. Because visible light may
cause photoreactivation of UV-damaged
microorganisms, we stored collected samples
in a dark box, blocked from visible light. We
repeated each experimental condition from
once to ﬁve times on the same day. We used
a positive hole conversion to estimate the
probable number of affected microorganisms
from recovered CFU (32).
Data analysis. The effect of UV irradia-
tion was expressed either as percent UV
effectiveness or equivalent ventilation rate
attributable to upper-room UVGI. We cal-
culated percent UV effectiveness as 100 × (1
– Cuv/Co) and calculated equivalent ventila-
tion rates using Equation 1:
Kuv = Ko (Co/Cuv – 1), [1]
where Cuv and Co represent the concentra-
tion of airborne culturable microorganisms
with and without upper-room UVGI,
respectively. Kuv represents equivalent venti-
lation rate (ACH) attributable to upper-
room UVGI; Ko represents ventilation rate
(ACH) without upper-room UVGI.
We performed two statistical analyses
[generalized liner model (GLM) and gener-
alized additive model (GAM)] to find the
relation between UV effectiveness and other
parameters. Microorganism strain type, use
of a fan, ACH, and the number of UV ﬁx-
tures were categorized and incorporated into
both the GLM and GAM by an indicator
variable. In the GLM, we assumed that
environmental factors (temperature, RH,
and temperature gradient between exhaust
and supply air) were linearly related to UV
effectiveness. The GAM does not have any
assumptions of a linear relationship between
environmental factors and UV effectiveness.
We used LOWESS—a nonparametric
smoothing technique that employs a run-
ning regression with a weight declining as
the cube of the distance from the center of
the neighborhood—to examine UV effec-
tiveness as a function of our predictors
(S-plus Version 4.5; Mathsoft Inc., Seattle,
WA).
Results
Percent recoveries and particle size distribu-
tion. Percent recoveries of total cells
aerosolized by nebulizer ranged from 5% to
28% for S. marcescens and from 21% to 25%
for BCG. Average number of S. marcescens
colonies counted on stages 1, 2, 3, 4, 5, and
6 were 1, 1, 7, 64, 144, and 3, respectively.
For BCG, the numbers were 2, 1, 12, 175,
681, and 85 on stages 1, 2, 3, 4, 5, and 6,
respectively. Particle size distributions of
recovered CFU from each stage of the
Andersen sampler are > 7 µm, 4.7–7 µm,
3.3–4.7 µm, 2.1–3.3 µm, 1.1–2.1 µm, and
0.65–1.1 µm for stages 1, 2, 3, 4, 5, and 6,
respectively. More than 90% of recovered
cells were from stages 3, 4, and 5 of the
Andersen sampler for all experiments, repre-
senting an aerodynamic diameter range from
1.1 to 4.7 µm. Count median diameter for S.
marcescens and BCG aerosols were approxi-
mately 1.6 and 1.3 µm, respectively. The RH
inside the room chamber was 46–64% for S.
marcescens and 64–70% for BCG. 
The effect of ACH and mixing fan on
UV effectiveness (with S. marcescens). The
number of CFU without upper-room UVGI
was 4 ± 6 (mean ± SD) on stage 2 and 207 ±
204 (mean ± SD) on stage 5. With upper-
room UVGI on, CFU counts were 2 ± 4 and
94 ± 161 on stages 2 and 5, respectively. We
calculated UV effectiveness from stage 5
colony counts only. The experimental results
with S. marcescens aerosols are summarized
in Table 1. Average UV effectiveness in inac-
tivating S. marcescens aerosols was 46%
(range: 22–80%) at 2 ACH and 53% (range:
40–68%) at 6 ACH with both ceiling- and
wall-mounted UV fixtures and without the
mixing fan. When the mixing fan was on,
the effectiveness of upper-room UVGI
increased to 62% (range: 50–78%) at
2 ACH and 86% (range: 81–89%) at
6 ACH (Figure 3). 
The efficacy of upper-room UVGI with
BCG. The experimental results with BCG
aerosols are summarized in Table 2 and
Figure 4. The number of CFUs without
upper-room UVGI was 1 ± 1 (mean ± SD)
on stage 2 and 146 ± 50 (mean ± SD) on
stage 5. With upper-room UVGI on, CFU
counts were 0 ± 0 and 70 ± 35 on stages 2
and 5, respectively. UV effectiveness calcu-
lated from stage 5 colony counts at 6 ACH
was 52% (range: 11–69%) with a ceiling-
mounted UV fixture only and 64% (range:
51–83%) with both ceiling- and wall-
mounted UV ﬁxtures. Equivalent ventilation
rates attributable to upper-room UVGI were
9.8 ± 6.4 ACH for the ceiling-mounted UV
ﬁxture, and 11.7 ± 7.1 ACH for both ceiling-
and wall-mounted UV ﬁxtures.
The regression models. Table 3 shows the
GLM results. The number of UV fixtures
(p < 0.01), ACH (p = 0.01), and use of mix-
ing fan (p < 0.01) were significantly associ-
ated with UV effectiveness. However, the
type of microorganism (S. marcescens vs.
BCG; p = 0.36), RH (p = 0.64), and temper-
ature gradient (exhaust air–supply air) (p =
0.27) are not significantly associated with
UV effectiveness. UV effectiveness increased
at higher temperature (p < 0.01) (Table 3).
Multiple R2 of the GLM is 0.54. Figure 5
shows the nonparametric smoothed curve of
UV effectiveness versus temperature gradi-
ent (exhaust air–supply air), temperature,
and RH from the GAM results. Better UV
effectiveness occurred at higher tempera-
tures. RH did not consistently affect UV
effectiveness. Higher UV effectiveness
occurred when cooler air was introduced
into the room from the supply air grill.
Nonparametric trends were significant for
temperature difference between supply and
exhaust air (p < 0.01), and RH (p = 0.05)
but not for temperature (p = 0.56) in the
GAM. Overall, results were similar. 
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Table 1. Summary of the experimental data on the efficacy of upper-room UVGI for inactivating
S. marcescens aerosols.
Type of Mechanical Equivalent
UV ventilation Temperature RH UV ventilation 
ﬁxture (ACH) Mixing fan (°C)a (%) Effectivenessb ratec
C 6.1 No 17–18 27–30 65 ± 11 12.7 ± 6.9
(n = 4) (13–15) (35–37)
C and W 6.0 No 4–8 30–41 53 ± 15 7.6 ± 4.3
(n = 4) (3–6) (35–41)
C and W 6.0 Yes 4–8 30–41 88 45.4
(n = 1) (3–6) (35–41)
C and W 6.0 Yes 8–9 31–52 84 ± 3 36.6 ± 9.8
(n = 5) (12–17) (31–40)
C and W 2.1 No 20 64 55 ± 30 4.1 ± 3.8
(n = 4) (21–25) (48–61)
C and W 2.0 No 6–12 44–52 29 ± 2 0.8 ± 0.0
(n = 2) (5–11) (47–51)
C and W 2.0 Yes 6–12 44–52 62 ± 12 3.8 ± 2.3
(n = 4) (5–11) (47–51)
Abbreviations: C, Ceiling-mounted UV ﬁxture containing four 9-W UV lamps; W, Wall-mounted UV ﬁxture containing one
23-W UV lamp. 
aTemperature or RH at the exhaust grill (temperature or RH at the supply grill). bUV effectiveness (%) = 100 × (1 –Cuv/Co),
where Cuv and Co are concentrations (or recovered CFU) with and without upper-room UVGI, respectively. cAdditionall
sanitary ACH attributable to upper-room UVGI. Equivalent ventilation rate = A × (Co/Cuv –1), where A is ventilation rate
without upper-room UVGI (ACH) and Cuv and Co are concentrations (or recovered CFU) with and without upper-room
UVGI respectively. Discussion
We have conﬁrmed that upper-room UVGI
can signiﬁcantly reduce the concentration of
culturable S. marcescens and BCG aerosols in
the lower room. Our ﬁndings and past stud-
ies with Mycobacterium sp. are summarized
in Table 4 (14,24). First, ﬁxture outputs in
Table 4 are less than the total UV output
because of luminaire inefficiency (the ratio
of luminous ﬂux emitted from the ﬁxture to
that emitted by the lamps), which depends
on the ﬁxture type (33). Our data showed a
lower UV effectiveness than those of the two
past studies (14,24). Some difference in UV
effectiveness may be caused by differences in
microbiologic factors (species, suspending
medium, physiologic condition), UV factors
(irradiance level, distribution), room factors
(air mixing, volume ratio of irradiated
upper-room to nonirradiated lower-room),
or environmental factors (temperature and
RH) or a combination of these. We used
10% FCS in the suspending medium to sim-
ulate saliva conditions, whereas previous
studies (14,24) used 0.2% bovine serum
albumin or distilled water. Past study indi-
cated that UV susceptibility of airborne bac-
teria depends greatly on the suspending
medium (25). Proteins coating cell surfaces
could protect airborne cells from harmful
UV light and other environmental stresses.
Therefore, to properly characterize UV sen-
sitivity of Mycobacterium aerosols in experi-
mental settings, suspending medium needs
to simulate the condition of aerosols released
from TB patients. 
Second, we did not use a mixing fan for
our BCG experiments. Our mixing fan
experiments with S. marcescens indicated an
increased UV efﬁciency of 63% at 6 ACH.
Third, different UV ﬁxture type and ratio of
UV output to room size would affect the
efﬁcacy of upper-room UVGI. We used lou-
vered UV ﬁxtures, whereas Riley’s study (14)
used open tube UV ﬁxtures without louvers.
Given the same UV output, louvered UV
fixtures produce 15 times less than those
without the louvers (20). Thus, this factor
alone could account for the observed differ-
ences in UV effectiveness. However, unlou-
vered fixtures are impractical in occupied
environments. Finally, we saw a strong cor-
relation with temperature, and the wide
range of room temperatures in our experi-
ments might explain some of the differences
observed. To estimate the efﬁcacy of upper-
room UVGI in reducing TB transmission,
all these factors should be considered. 
Particles from 1 µm to 5 µm were our
main interest because only those particles can
reach the lower respiratory tract and cause dis-
ease (34). In our study, more than 90% of
recovered microorganisms ranged from 0.6
µm to 3.0 µm as measured by cascade
impaction. Airborne particle size is crucial in
the UV sensitivity of microorganism, and air-
borne microorganisms borne on large parti-
cles tend to be more resistant to UV than
those associated with smaller particles (35,36).
The count median diameters (approximately
1.6 µm for S. marcescens; 1.4 µm for BCG)
in the studies presented here were smaller
than those within a similar RH range in a
smaller chamber (approximately 2.1 µm for
S. marcescens; 2.2 µm for BCG) (36). The
room chamber (46 m3) in this study is much
larger than the bench size chamber (< 0.01
m3) in the previous study (36), and longer
residence times may contribute to preferen-
tial removal of the larger particles or to more
evaporation from individual droplets. Most
of aerosolized bacteria (both S. marcescens
and BCG) would be a singlet given that the
size of those microorganisms is 1–2 µm.
Some fraction of aerosolized cells in our
study could be 2 or 3 multiple organisms.
Those multiple organisms ranging from 1 to
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Table 2. Summary of the experimental data on the efficacy of upper-room UVGI for inactivating BCG
aerosols.
Type of UV Temperature RH UV Equivalent
ﬁxture ACH (°C)a (%) effectivenessb ventilation ratec
C 8.6 23–26 46–64 66 ± 6 17.4 ± 4.4
(n = 4) (20–21) (87–90)
C 6.2 22–24 62–70 64 ± 5 11.1 ± 2.4
(n = 4) (21–22) (73–78)
C 6.1 18–22 46–57 37 ± 18 4.3 ± 3.1
(n = 4) (19–22) (49–59)
C 6.1 8–9 31–52 25 ± 20 2.3 ± 2.2
(n = 2) (4–6) (47–60)
C and W 5.7 9–14 33–41 70 ± 10 15.4 ± 9.0
(n = 4) (9–12) (44–45)
C and W 6.1 11–16 46–50 56 ± 39 8.1 ± 1.6
(n = 4) (8–9) (59–61)
Abbreviations: C, Ceiling-mounted UV ﬁxture containing four 9-W UV lamps; W, Wall-mounted UV ﬁxture containing one
23-W UV lamp. 
aTemperature or RH at the exhaust grill (temperature or RH at the supply grill). bUV effectiveness (%) = 100 × (1 – Cuv/Co),
where Cuv and Co are concentrations (or recovered CFU) with and without upper-room UVGI, respectively. cAdditional
sanitary ACH attributable to upper-room UVGI. Equivalent ventilation rate = A × (Co/Cuv – 1), where A is ventilation rate
without upper room UVGI (ACH) and Cuv and Co are concentrations (or recovered CFU) with and without upper-room
UVGI, respectively. 
Table 3. The results of GLM (multiple R2 = 0.54).
Parametera Value SE t-Value p-Value
Intercept –7.0 19.9 –0.35 0.58
Microorganism –6.7 7.3 –0.92 0.26
UV ﬁxture 27.6 7.9 3.5 < 0.01
ACH 24.6 9.5 2.61 0.01
Fan 16.5 6.3 2.60 < 0.01
Temperature 2.4 0.7 3.69 < 0.01
RH –0.16 0.33 –0.47 0.21
Temperature difference 1.96 1.75 1.12 0.22
aMicroorganism (S. marcescens = 0, BCG = 1), UV ﬁxture (ceiling-mounted only = 0, ceiling- and wall-mounted = 1), ACH
(2 ACH = 0, 6 ACH = 1), fan (no use = 0, use = 1). Temperature, RH, and temperature difference between exhaust and sup-
ply air were incorporated into model as continuous variables. 
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Figure 3. The effect of ACH and mixing fan on UV
effectiveness for inactivating S. marcescens.
Both ceiling- and wall-mounted UV ﬁxtures were
used. Each experiment was repeated four times.
Figure 4. UV effectiveness for inactivating BCG
aerosols with either ceiling-mounted (C) or wall-
mounted (CW) UV fixtures. Ceiling-mounted UV
ﬁxture contains four 9-W UV lamps; wall-mounted
UV ﬁxture contains one 23-W UV lamp.5 µm could be of particular concern because
they are small enough to reach the alveolar
region in the lung for established infection
and likely are more resistant to UV as well.
Mycobacterium sp. tends to form clumps in
culture because of their waxy surface, so mul-
tiple organisms of Mycobacterium aerosols are
very likely released from the infectious TB
patient. Therefore, the level of multiple
organisms among airborne microorganisms
released from the infectious TB patient must
be characterized.
We express the efficacy of upper-room
UVGI both in terms of the percent of UV
effectiveness and as an equivalent ventilation
rate. The percent UV effectiveness is deﬁned
as 100 × (1 – Cuv/Co) where Cuv and Co are
the concentrations with and without upper-
room UVGI. The equivalent ventilation rate
expresses the UVGI effect as the amount of
ventilation with fresh air that would be
required to achieve an equivalent reduction
in the concentration of airborne microorgan-
isms. Because percent UV effectiveness is
related to the concentration ratio, it is more
directly applied to the risk ratio between UV
on and off. Thus, if UV effectiveness is 50%,
given the same exposure time UV would
reduce the risk of infection by 50%. The
relationship between ventilation rate and
particle concentration is nonlinear, so a
small reduction in airborne particle concen-
tration may require large increases in ventila-
tion. For virulent infectious agents, even low
residual concentrations may be associated
with signiﬁcant risk.
The importance of air mixing in the
efficacy of upper-room UVGI has been
addressed in past studies (17,37) and was
conﬁrmed in our studies. The use of a mix-
ing fan increased UV effectiveness on aver-
age by 72% at 6 ACH and 63% at 2 ACH.
Our results indicated that UV effectiveness is
also strongly inﬂuenced by the air exchange
rate (Figure 3). UV effectiveness in inactivat-
ing S. marcescens aerosols increased by 46%
with an increase in ACH from 2 to 6
(p = 0.01). Higher air velocity from the sup-
ply grill at 6 ACH might have caused better
vertical air mixing, leading to increased UV
effectiveness. Although it is not statistically
significant in the model (p = 0.27), UV
effectiveness also increased with temperature
gradient (exhaust–supply air) (Table 3 and
Figure 5A). Temperature gradients can have
signiﬁcant effects on internal air mixing. 
UV effectiveness signiﬁcantly increased at
higher temperature (Table 3 and Figure 5B).
This temperature effect on the efficacy of
upper-room UVGI has not been previously
reported, possibly because most experiments
were performed at room temperature
(14,17,22–24,35,38) The temperatures in
our study ranged widely from near freezing
(4°C) to room temperature (25°C). Some of
our experimental results at lower tempera-
tures might not be directly applicable to risk
settings that are temperature controlled to
typical room temperature, and therefore
require careful data interpretation. However,
our multivariate statistical analyses allow con-
sideration of all the variables individually and
interactively. Thus, we can interpret our data
for room temperature environments as well
as for colder environments such as might
occur in shelters in very cold climates or in
artificially controlled cold rooms. The
reduced efficacy of upper-room UVGI at
lower temperature may be caused by reduced
UV output from the lamps, reduced sensitiv-
ity of microorganisms at lower temperature,
or a combination effect of UV output and
microorganism’s sensitivity. UV outputs
from the low pressure mercury lamps are
determined by the pressure of the mercury,
which is closely related to the ambient tem-
perature (19). It has also been reported that
fewer airborne microorganisms survive at
high temperatures (39–41). Higher suscepti-
bility at higher temperatures might be caused
by structural changes in membrane phospho-
lipids, proteins, and DNA (26,38). UVC
may act synergistically to augment this gen-
eral temperature sensitivity. Interestingly, a
synergistic effect of UVA and elevated tem-
perature on the survival of the convict cichlid
fish (Cichlasoma nigrofasciatum) has been
reported (42). Another possible explanation
Articles • Ko et al.
100 VOLUME 110 | NUMBER 1 | January 2002 • Environmental Health Perspectives
Figure 5. Partial residual plots for the relationship between UV effectiveness and environmental factors from general additive model (GAM). 
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Table 4. Summary of previous and our upper-room UVGI experiments in inactivating Mycobacterium sp.
aerosols.
Riley (14) Miller (24) Our study
Parameters Setting 1 Setting 2 Setting 1 Setting 2 Setting 1 Setting 2
Microorganism BCG M. parafortuitum BCG
Particle size (µm) 0.5–3 0.65–2.1 1.1–4.7a
Suspending medium 0.2% BSA DW 10% FCS
Temperature (°C) NA NA 15-35 4–26
RH (%) 25 20, 40 50-90 41–69
Room size (m3)6 1 9 04 6
Mechanical ventilation No Yes Yes
ACH 2 2–4 0 6 6-8 6
Mixing fan Yes Yes No
(during aerosolization)
UV output (W) 17 46 99(28)b 99(28) 36(10) 59(15)
UV output/room size (W/m3) 0.28 0.75 1.1 1.1 0.78 1.3
UV ﬁxture type C1 C1, W CN, C2 CN, C2 C2 C2, W
UV effectivenessc (%) 83 88, 89 98 95 52 ± 19 64 ± 10
(56 ± 17)d
UV effecte (ACH) 10 18–19, 33 120 9.8 ± 6.4 11.7 ± 7.1
(10.9 ± 6.1)
Abbreviations: BSA, bovine serum albumin; C1, open-tube ceiling-mounted ﬁxture; C2, louvered ceiling-mounted ﬁxture;
CN, louvered corner-mounted fixture; DW, distilled water; NA, not available; W, louvered wall-mounted fixture. Each
study was done under two sets of different conditions.
aParticle size distribution of recovered BCG aerosols (80%: 1.1–2.1 µm; 19%: 2.1–3.3 µm; 1%: 3.3–4.7 µm). bUV lamp power
(UV output). cPercent UV effectiveness = 100 (1 - Cuv/Co), where Cuv and Co are concentration with and without upper-
room UVGI. dOnly data with room temperature (18–25°C). eEquivalent ventilation rate attributable to UV = A (Co/Cuv – 1),
where A is ACH and Cuv and Co are concentrations with and without upper-room UVGI.for higher UV sensitivity at higher tempera-
ture is that UV is more likely to cause
mutagenic effects on DNA [e.g., cis-syn
cyclobutane-pyrimidine dimers and pyrimi-
dine (6-4) pyrimidine photoproducts] at
higher temperatures. The ability of UVC to
damage a given base is determined by the
ﬂexibility of the DNA (43,44). The DNA of
airborne microorganisms becomes more ﬂexi-
ble at higher temperature because of active
metabolism and a direct temperature effect
on DNA. 
Previous studies have indicated that UV
effectiveness decreases at higher RH, espe-
cially > 75% RH.(36,45) Decreased UV
effectiveness at high RH (> 80%) may be
explained partially by increased particle size
of airborne microorganisms at high RH.
However, the RH effect on UV effectiveness
was not significant in our study (Table 3,
Figure 5C), probably because the RH range
was limited (27–64%). In addition to RH,
we used the absolute humidity—the ratio of
the mass of water vapor to the total volume
of the mixture—to examine the effect of dif-
ferent saturation vapor pressures at different
RHs. However, we did not observe any sig-
niﬁcant relationship between the efﬁcacy of
upper-room UVGI and absolute humidity.
In conclusion, we have found that upper-
room UVGI can signiﬁcantly reduce the con-
centration of airborne microorganisms (S.
marcescens and BCG) aerosolized in a saliva
simulant in a typical mechanically ventilated
hospital isolation room. Because upper-room
UVGI varied signiﬁcantly with environmen-
tal factors such as temperature, air mixing,
and air exchange rate, it is important to opti-
mize environmental conditions to produce
the best and most persistent effect in reduc-
ing the risk of TB in high-risk settings. 
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